Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen

Thorax

Volumn 56, Issue 2, 2001, Pages 115-120

  Hohenadel, I A ^a   Kiworr, M ^b   Genitsariotis, R ^b   Zeidler, D ^a   Lorenz, J ^c  

^a Academic Teaching Hospital   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Academic Teaching Hospital   (Germany)

Author keywords

Bronchoalveolar lavage; Immunosuppression; Pneumonia

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; C REACTIVE PROTEIN; CEFTRIAXONE; TEICOPLANIN; TOBRAMYCIN;

ADULT; ARTICLE; BACTERIUM ISOLATION; CYTOMEGALOVIRUS; DIAGNOSTIC VALUE; FEMALE; FEVER; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE DEFICIENCY; LUNG INFILTRATE; LUNG LAVAGE; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; PNEUMONIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY; THROMBOCYTOPENIA;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CANDIDA; CHI-SQUARE DISTRIBUTION; CYTOMEGALOVIRUS; DRUG RESISTANCE, MULTIPLE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MYCOBACTERIUM; NEUTROPENIA; PNEUMONIA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SPUTUM; STATISTICS, NONPARAMETRIC;

EID: 0035122822     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.2.115     Document Type: Article

References (30)

1. Antimicrobial chemotherapy for Legionnaire's disease: A review
2. State of art: Bronchoalveolar lavage
3. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage
4. Empirische antimikrobielle Therapie bei neutropenischen Patienten
5. The GLM procedure SAS user's guide
6. Fiberoptic bronchoscopy in diagnosis of opportunistic lung infections
7. Role of bronchoalveolar lavage in the assessment of opportunistic pulmonary infections: Utility and complications
8. Bronchoalveolar lavage in diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host
9. Diagnostic value of bronchoalveolar lavage in patients with opportunistic and nonopportunistic bacterial pneumonia
10. The yield of bronchoalveolar lavage in the etiologically diagnosis of pneumonia in leukemia and lymphoma patients
11. Pulmonary infiltrates in patients with hematologic malignancies: Clinical usefulness of non-invasive bronchoscopic procedures
12. Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogenic bone marrow transplantation
13. Pulmonary infiltrates in immunocompromised patients. Diagnosis by cytologic examination of bronchoalveolar lavage fluid
14. Etiology of community acquired pneumonia
15. Opportunistic infection complicating acquired immune deficiency syndrome
16. The role of bronchoalveolar lavage in HIV-infected patients with pneumonia in comparison to non-invasive procedures
17. The prevalence of nosocomial infections in intensive care units in Europe
18. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients
19. Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies
20. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis
21. Pulmonary disease in the immunocompromised host
22. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia
23. Pulmonary infiltrations in febrile patients with neutropenia
24. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis
25. Pneumonien bei abwehrgeschwächten Patienten: Stellenwert nicht bioptischer bronchoskopischer Untersuchungsverfahren in der Erregerdiagnostik
26. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study
27. Mycobacteria other than tuberculosis. Pulmonary involvement in patients with acquired immunodeficiency syndrome
28. Analysis of bronchoalveolar lavage specimens from immunocompromised patients with a protocol applicable in the microbiology laboratory
29. Pulmonary hemorrhage in fiberoptic transbronchial biopsy